71261-64-8

71261-64-8 structure
71261-64-8 structure
  • Name: Alanine-15N
  • Chemical Name: 2-azanylpropanoic acid
  • CAS Number: 71261-64-8
  • Molecular Formula: C3H7NO2
  • Molecular Weight: 89.093
  • Catalog: Research Areas Metabolic Disease
  • Create Date: 2018-05-07 08:00:00
  • Modify Date: 2024-01-09 16:07:23
  • DL-Alanine-15N is the 15N labeled DL-Alanine[1]. DL-alanine, an amino acid, is the racemic compound of L- and D-alanine. DL-alanine is employed both as a reducing and a capping agent, used with silver nitrate aqueous solutions for the production of nanoparticles. DL-alanine can be used for the research of transition metals chelation, such as Cu(II), Zn(II), Cd(11). DL-alanine, a sweetener, is classed together with glycine, and sodium saccharin. DL-alanine plays a key role in the glucose-alanine cycle between tissues and liver[2][3][4][5][6][7].

Name 2-azanylpropanoic acid
Synonyms (R,S)-Alanine
(±)-Alanine
Propanoic acid, 2-amino-
DL-Alanine-15N
DL-2-aminopropionic acid
α-Aminopropanoic acid
(15N)-dl-alanine
2-Aminopropanoic acid
(15)N-alanine
ZY1&VQ
Alanine
α-Aminopropionic acid
d,l-alanine
DL-15N-alanine
Alanine, DL-
UNII:1FU7983T0U
α-Alanine
MFCD00064409
2-Aminopropionic Acid
DL-α-Aminopropionic acid
H-DL-Ala-OH
DL-2-Aminopropanoic acid
DL-α-Alanine
DL-Aminopropanoic acid
Methyl glycine
Description DL-Alanine-15N is the 15N labeled DL-Alanine[1]. DL-alanine, an amino acid, is the racemic compound of L- and D-alanine. DL-alanine is employed both as a reducing and a capping agent, used with silver nitrate aqueous solutions for the production of nanoparticles. DL-alanine can be used for the research of transition metals chelation, such as Cu(II), Zn(II), Cd(11). DL-alanine, a sweetener, is classed together with glycine, and sodium saccharin. DL-alanine plays a key role in the glucose-alanine cycle between tissues and liver[2][3][4][5][6][7].
Related Catalog
In Vitro Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1].
References

[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216.  

[2]. Amrallah AH, et al. Mixed ligand complexes of benzimidazole and pyrimidine hydroxy azo dyes with some transition metals and glycine, dl-alanine or dl-leucine. Talanta. 1998 Aug;46(4):491-500.  

[3]. Eder José Guidelli, et, al. Synthesis of silver nanoparticles using dl-alanine for ESR dosimetry applications. Radiation Physics and Chemistry. Volume 81, Issue 3, 2012: Pages 301-307.

[4]. Rashid M, et al. Biosynthesis of Self-Dispersed Silver Colloidal Particles Using the Aqueous Extract of P. peruviana for Sensing dl-Alanine[J]. Isrn Nanotechnology, 2014, 2014:1-7.

[5]. Tapper DN, et al. Taste stimuli: a behavioral categorization. Science. 1968 Aug 16161(3842):708-10.  

[6]. Yamaguchi M, et al. Terahertz absorption spectra of L-, D-, and DL-alanine and their application to determination of enantiometric composition[J]. Applied Physics Letters, 2005, 86(5): 053903.

[7]. Yamamoto T, et al. Gustatory reaction time to various sweeteners in human adults. Physiol Behav. 1985 Sep35(3):411-5.  

Density 1.2±0.1 g/cm3
Boiling Point 212.9±23.0 °C at 760 mmHg
Melting Point 289ºC (dec.)(lit.)
Molecular Formula C3H7NO2
Molecular Weight 89.093
Flash Point 82.6±22.6 °C
Exact Mass 89.047676
PSA 63.32000
LogP -0.68
Vapour Pressure 0.1±0.9 mmHg at 25°C
Index of Refraction 1.460
RIDADR NONH for all modes of transport